Literature DB >> 2445587

Four epitopes on the rat 55-kDa subunit of the interleukin 2 receptor as defined by newly developed mouse anti-rat interleukin 2 receptor monoclonal antibodies.

A Mouzaki1, T Diamantstein.   

Abstract

Four new mouse monoclonal antibodies (mAb), ART-38, ART-35, ART-75 and ART-94, directed against the rat interleukin 2 receptor (IL 2R) have been developed. As shown by immunoprecipitation studies they all recognize specifically the 55-kDa subunit of the rat IL 2R. These mAb were compared to three previously characterized mouse mAb directed against the 55-kDa molecule of the rat IL 2R, namely the ART-18, ART-65 and OX-39 mAb. Out of all seven mAb, only ART-18 and OX-39 were found to inhibit the IL 2 binding to activated T cells, while IL 2R inhibited the binding of ART-18 alone. ART-18 was the only mAb found to inhibit the IL 2-dependent proliferation of cells carrying the IL 2R. Scatchard plot analyses showed gross differences in the numbers of mAb-binding sites ranging between 30,000 (ART-65) and 165,000 (ART-75) as well as in their affinities which ranged between 2.5 X 10(-9) M (ART-38) and 8.3 X 10(-10) M (OX-39). Cross inhibition studies revealed that the mAb recognize four different epitopes on the 55-kDa rat IL 2R subunit.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445587     DOI: 10.1002/eji.1830171123

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  4 in total

1.  Demonstration of two distinct forms of released low affinity-type rat IL-2 receptors.

Authors:  T Herrmann; O Josimovic-Alasevic; A Mouzaki; T Diamantstein
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

2.  Four interleukin-2 surface binding proteins detected in rat spleen cells.

Authors:  R K Chopra; M P Carroll; W S May; S K Bhatia; J B Margolick; J E Nagel; W H Adler
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

3.  Anti-IL-2 receptor monoclonal antibody AMT-13 increases soluble IL-2 receptor levels in vivo.

Authors:  K Burkhardt; T E Mandel; T Diamantstein; M S Loughnan
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

4.  Anti-interleukin 2 receptor monoclonal antibodies spare phenotypically distinct T suppressor cells in vivo and exert synergistic biological effects.

Authors:  R Di Stefano; A Mouzaki; D Araneda; T Diamantstein; N L Tilney; J W Kupiec-Weglinski
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.